株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アジア太平洋地域におけるオーソバイオロジクス市場の見通し

Asia-Pacific Orthobiologics Market Outlook to 2021

発行 GlobalData 商品コード 297570
出版日 ページ情報 英文 196 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: GlobalData社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
アジア太平洋地域におけるオーソバイオロジクス市場の見通し Asia-Pacific Orthobiologics Market Outlook to 2021
出版日: 2015年10月01日 ページ情報: 英文 196 Pages
概要

当レポートでは、アジア太平洋地域におけるオーソバイオロジクス市場について調査分析し、主要な市場データ(収益、数量、平均価格、企業シェア、流通シェア)を提供し、主要企業プロファイルなどを含めて、概略以下の構成でお届けいたします。

第1章 目次

第2章 イントロダクション

第3章 アジア太平洋地域におけるオーソバイオロジクス市場

  • 収益
  • カテゴリー比較:収益別
  • 収益(実績)
  • 収益(予測)
  • 数量(実績)
  • 数量(予測)
  • 企業シェア:収益別

第4章 オーストラリアのオーソバイオロジクス市場

  • 収益(実績)
  • 収益(予測)
  • 数量(実績)
  • 数量(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第5章 中国のオーソバイオロジクス市場

  • 収益(実績)
  • 収益(予測)
  • 数量(実績)
  • 数量(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第6章 インドのオーソバイオロジクス市場

  • 収益(実績)
  • 収益(予測)
  • 数量(実績)
  • 数量(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第7章 日本のオーソバイオロジクス市場

  • 収益(実績)
  • 収益(予測)
  • 数量(実績)
  • 数量(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第8章 韓国のオーソバイオロジクス市場

  • 収益(実績)
  • 収益(予測)
  • 数量(実績)
  • 数量(予測)
  • 平均価格
  • 流通シェア:収益別
  • 企業シェア:収益別

第9章 アジア太平洋地域におけるオーソバイオロジクス市場における主要企業の概要

  • DePuy Companies
  • 生化学工業
  • Sanofi
  • Medtronic, Inc.
  • Baxter International Inc.
  • Biomet, Inc.
  • Stryker Corporation
  • Smith & Nephew Plc
  • DJO Finance LLC
  • Wright Medical Group, Inc.

第10章 オーソバイオロジクス市場のパイプライン製品

第11章 財務取引情勢

  • 資産取引
  • パートナーシップ

第12章 最近の発展動向

  • 決算発表
  • 法規制
  • 戦略と事業計画

第13章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECR0301DB

GlobalData's new report, "Asia-Pacific Orthobiologics Market Outlook to 2021", provides key market data on the Asia-Pacific Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Bone Graft and Substitutes, Bone Growth Stimulators and Viscosupplementation.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country/region, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Orthobiologics market categories - Bone Graft and Substitutes, Bone Growth Stimulators and Viscosupplementation.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Orthobiologics market.
  • Global corporate-level profiles of key companies operating within the Asia-Pacific Orthobiologics market.
  • Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Orthobiologics Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Orthobiologics Market, Asia-Pacific

  • 3.1. Orthobiologics Market, Asia-Pacific, Revenue ($m), 2007-2021
  • 3.2. Orthobiologics Market, Asia-Pacific, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Orthobiologics Market, Asia-Pacific, Revenue ($m), 2007-2014
  • 3.4. Orthobiologics Market, Asia-Pacific, Revenue ($m), 2014-2021
  • 3.5. Orthobiologics Market, Asia-Pacific, Volume (Units), 2007-2021
  • 3.6. Orthobiologics Market, Asia-Pacific, Volume (Units), 2007-2014
  • 3.7. Orthobiologics Market, Asia-Pacific, Volume (Units), 2014-2021
  • 3.8. Orthobiologics Market, Asia-Pacific, Company Share by Revenue ($m), 2014

4. Orthobiologics Market, Australia

  • 4.1. Orthobiologics Market, Australia, Revenue ($m), 2007-2014
  • 4.2. Orthobiologics Market, Australia, Revenue ($m), 2014-2021
    • 4.2.1. Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2007-2014
    • 4.2.2. Bone Grafts and Substitutes Market, Australia, Revenue ($m), by Segment, 2014-2021
  • 4.3. Orthobiologics Market, Australia, Volume (Units), 2007-2014
  • 4.4. Orthobiologics Market, Australia, Volume (Units), 2014-2021
    • 4.4.1. Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2007-2014
    • 4.4.2. Bone Grafts and Substitutes Market, Australia, Volume (Units), by Segment, 2014-2021
  • 4.5. Orthobiologics Market, Australia, Average Price ($), 2007-2021
  • 4.6. Orthobiologics Market, Australia, Distribution Share by Revenue ($m), 2013-2014
  • 4.7. Orthobiologics Market, Australia, Company Share by Revenue ($m), 2014

5. Orthobiologics Market, China

  • 5.1. Orthobiologics Market, China, Revenue ($m), 2007-2014
  • 5.2. Orthobiologics Market, China, Revenue ($m), 2014-2021
    • 5.2.1. Bone Grafts and Substitutes Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.2. Bone Growth Stimulators Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.3. Viscosupplementation Market, China, Revenue ($m), by Segment, 2007-2014
    • 5.2.4. Bone Grafts and Substitutes Market, China, Revenue ($m), by Segment, 2014-2021
    • 5.2.5. Bone Growth Stimulators Market, China, Revenue ($m), by Segment, 2014-2021
    • 5.2.6. Viscosupplementation Market, China, Revenue ($m), by Segment, 2014-2021
  • 5.3. Orthobiologics Market, China, Volume (Units), 2007-2014
  • 5.4. Orthobiologics Market, China, Volume (Units), 2014-2021
    • 5.4.1. Bone Grafts and Substitutes Market, China, Volume (Units), by Segment, 2007-2014
    • 5.4.2. Bone Growth Stimulators Market, China, Volume (Units), by Segment, 2007-2014
    • 5.4.3. Viscosupplementation Market, China, Volume (Units), by Segment, 2007-2014
    • 5.4.4. Bone Grafts and Substitutes Market, China, Volume (Units), by Segment, 2014-2021
    • 5.4.5. Bone Growth Stimulators Market, China, Volume (Units), by Segment, 2014-2021
    • 5.4.6. Viscosupplementation Market, China, Volume (Units), by Segment, 2014-2021
  • 5.5. Orthobiologics Market, China, Average Price ($), 2007-2021
  • 5.6. Orthobiologics Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 5.7. Orthobiologics Market, China, Company Share by Revenue ($m), 2014

6. Orthobiologics Market, India

  • 6.1. Orthobiologics Market, India, Revenue ($m), 2007-2014
  • 6.2. Orthobiologics Market, India, Revenue ($m), 2014-2021
    • 6.2.1. Bone Grafts and Substitutes Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.2. Viscosupplementation Market, India, Revenue ($m), by Segment, 2007-2014
    • 6.2.3. Bone Grafts and Substitutes Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.2.4. Bone Growth Stimulators Market, India, Revenue ($m), by Segment, 2014-2021
    • 6.2.5. Viscosupplementation Market, India, Revenue ($m), by Segment, 2014-2021
  • 6.3. Orthobiologics Market, India, Volume (Units), 2007-2014
  • 6.4. Orthobiologics Market, India, Volume (Units), 2014-2021
    • 6.4.1. Bone Grafts and Substitutes Market, India, Volume (Units), by Segment, 2007-2014
    • 6.4.2. Viscosupplementation Market, India, Volume (Units), by Segment, 2007-2014
    • 6.4.3. Bone Grafts and Substitutes Market, India, Volume (Units), by Segment, 2014-2021
    • 6.4.4. Bone Growth Stimulators Market, India, Volume (Units), by Segment, 2014-2021
    • 6.4.5. Viscosupplementation Market, India, Volume (Units), by Segment, 2014-2021
  • 6.5. Orthobiologics Market, India, Average Price ($), 2007-2021
  • 6.6. Orthobiologics Market, India, Distribution Share by Revenue ($m), 2013-2014
  • 6.7. Orthobiologics Market, India, Company Share by Revenue ($m), 2014

7. Orthobiologics Market, Japan

  • 7.1. Orthobiologics Market, Japan, Revenue ($m), 2007-2014
  • 7.2. Orthobiologics Market, Japan, Revenue ($m), 2014-2021
    • 7.2.1. Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.2. Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.3. Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2007-2014
    • 7.2.4. Bone Grafts and Substitutes Market, Japan, Revenue ($m), by Segment, 2014-2021
    • 7.2.5. Bone Growth Stimulators Market, Japan, Revenue ($m), by Segment, 2014-2021
    • 7.2.6. Viscosupplementation Market, Japan, Revenue ($m), by Segment, 2014-2021
  • 7.3. Orthobiologics Market, Japan, Volume (Units), 2007-2014
  • 7.4. Orthobiologics Market, Japan, Volume (Units), 2014-2021
    • 7.4.1. Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2007-2014
    • 7.4.2. Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2007-2014
    • 7.4.3. Viscosupplementation Market, Japan, Volume (Units), by Segment, 2007-2014
    • 7.4.4. Bone Grafts and Substitutes Market, Japan, Volume (Units), by Segment, 2014-2021
    • 7.4.5. Bone Growth Stimulators Market, Japan, Volume (Units), by Segment, 2014-2021
    • 7.4.6. Viscosupplementation Market, Japan, Volume (Units), by Segment, 2014-2021
  • 7.5. Orthobiologics Market, Japan, Average Price ($), 2007-2021
  • 7.6. Orthobiologics Market, Japan, Distribution Share by Revenue ($m), 2013-2014
  • 7.7. Orthobiologics Market, Japan, Company Share by Revenue ($m), 2014

8. Orthobiologics Market, South Korea

  • 8.1. Orthobiologics Market, South Korea, Revenue ($m), 2007-2014
  • 8.2. Orthobiologics Market, South Korea, Revenue ($m), 2014-2021
    • 8.2.1. Bone Grafts and Substitutes Market, South Korea, Revenue ($m), by Segment, 2007-2014
    • 8.2.2. Bone Grafts and Substitutes Market, South Korea, Revenue ($m), by Segment, 2014-2021
  • 8.3. Orthobiologics Market, South Korea, Volume (Units), 2007-2014
  • 8.4. Orthobiologics Market, South Korea, Volume (Units), 2014-2021
    • 8.4.1. Bone Grafts and Substitutes Market, South Korea, Volume (Units), by Segment, 2007-2014
    • 8.4.2. Bone Grafts and Substitutes Market, South Korea, Volume (Units), by Segment, 2014-2021
  • 8.5. Orthobiologics Market, South Korea, Average Price ($), 2007-2021
  • 8.6. Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), 2013-2014
  • 8.7. Orthobiologics Market, South Korea, Company Share by Revenue ($m), 2014

9. Overview of Key Companies in Asia-Pacific Orthobiologics Market

  • 9.1. DePuy Companies
    • 9.1.1. Company Overview
  • 9.2. Medtronic plc
    • 9.2.1. Company Overview
  • 9.3. Seikagaku Corporation
    • 9.3.1. Company Overview
  • 9.4. Cellumed Co. Ltd.
    • 9.4.1. Company Overview
  • 9.5. Bioventus LLC
    • 9.5.1. Company Overview
  • 9.6. Arthrex, Inc.
    • 9.6.1. Company Overview
  • 9.7. Sanofi
    • 9.7.1. Company Overview
  • 9.8. Stryker Corporation
    • 9.8.1. Company Overview
  • 9.9. Bloomage Freda Biopharm Co., Ltd
    • 9.9.1. Company Overview
  • 9.10. Qingdao Haitao Biochemical Co.,Ltd
    • 9.10.1. Company Overview

10. Orthobiologics Market Pipeline Products

11. Recent Developments

  • 11.1. Government and Public Interest
    • 11.1.1. Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
  • 11.2. Other Significant Developments
    • 11.2.1. Feb 10, 2015: The biggest R&D investment in 2014, 20.0% of sales revenue

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Market Modeling and Forecasting
    • 12.1.5. Company Share Analysis
    • 12.1.6. Distribution Share Analysis
  • 12.2. Expert Panel
  • 12.3. GlobalData Consulting
  • 12.4. Contact Us
  • 12.5. Disclaimer

List of Tables

  • Table 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Orthobiologics Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Orthobiologics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Orthobiologics Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Orthobiologics Market, Asia-Pacific, Volume (Units), 2007-2021
  • Table 6: Orthobiologics Market, Asia-Pacific, Volume (Units), Historic, 2007-2014
  • Table 7: Orthobiologics Market, Asia-Pacific, Volume (Units), Forecast, 2014-2021
  • Table 8: Orthobiologics Market, Asia-Pacific, Company Share by Revenue ($m), USD Constant, 2014
  • Table 9: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 10: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 11: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 12: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 13: Orthobiologics Market, Australia, Volume (Units), Historic, 2007-2014
  • Table 14: Orthobiologics Market, Australia, Volume (Units), Forecast, 2014-2021
  • Table 15: Bone Grafts and Substitutes Market, Australia, Volume (Units), Historic, 2007-2014
  • Table 16: Bone Grafts and Substitutes Market, Australia, Volume (Units), Forecast, 2014-2021
  • Table 17: Orthobiologics Market, Australia, Average Price ($), Historic, 2007-2014
  • Table 18: Orthobiologics Market, Australia, Average Price ($), Forecast, 2014-2021
  • Table 19: Orthobiologics Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 20: Orthobiologics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014
  • Table 21: Orthobiologics Market, Australia, Company Share by Revenue ($m), USD Constant, 2014
  • Table 22: Orthobiologics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 23: Orthobiologics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 24: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 25: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 26: Viscosupplementation Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 27: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 28: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 29: Viscosupplementation Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 30: Orthobiologics Market, China, Volume (Units), Historic, 2007-2014
  • Table 31: Orthobiologics Market, China, Volume (Units), Forecast, 2014-2021
  • Table 32: Bone Grafts and Substitutes Market, China, Volume (Units), Historic, 2007-2014
  • Table 33: Bone Growth Stimulators Market, China, Volume (Units), Historic, 2007-2014
  • Table 34: Viscosupplementation Market, China, Volume (Units), Historic, 2007-2014
  • Table 35: Bone Grafts and Substitutes Market, China, Volume (Units), Forecast, 2014-2021
  • Table 36: Bone Growth Stimulators Market, China, Volume (Units), Forecast, 2014-2021
  • Table 37: Viscosupplementation Market, China, Volume (Units), Forecast, 2014-2021
  • Table 38: Orthobiologics Market, China, Average Price ($) Historic, 2007-2014
  • Table 39: Orthobiologics Market, China, Average Price ($), Forecast, 2014-2021
  • Table 40: Orthobiologics Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 41: Orthobiologics Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 42: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 43: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 44: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 45: Viscosupplementation Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 46: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 47: Bone Growth Stimulators Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 48: Viscosupplementation Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 49: Orthobiologics Market, India, Volume (Units), Historic, 2007-2014
  • Table 50: Orthobiologics Market, India, Volume (Units), Forecast, 2014-2021
  • Table 51: Bone Grafts and Substitutes Market, India, Volume (Units), Historic, 2007-2014
  • Table 52: Viscosupplementation Market, India, Volume (Units), Historic, 2007-2014
  • Table 53: Bone Grafts and Substitutes Market, India, Volume (Units), Forecast, 2014-2021
  • Table 54: Bone Growth Stimulators Market, India, Volume (Units), Forecast, 2014-2021
  • Table 55: Viscosupplementation Market, India, Volume (Units), Forecast, 2014-2021
  • Table 56: Orthobiologics Market, India, Average Price ($) Historic, 2007-2014
  • Table 57: Orthobiologics Market, India, Average Price ($), Forecast, 2014-2021
  • Table 58: Orthobiologics Market, India, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 59: Orthobiologics Market, India, Company Share by Revenue ($m), USD Constant, 2014
  • Table 60: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 61: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 62: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 63: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 64: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 65: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 66: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 67: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 68: Orthobiologics Market, Japan, Volume (Units), Historic, 2007-2014
  • Table 69: Orthobiologics Market, Japan, Volume (Units), Forecast, 2014-2021
  • Table 70: Bone Grafts and Substitutes Market, Japan, Volume (Units), Historic, 2007-2014
  • Table 71: Bone Growth Stimulators Market, Japan, Volume (Units), Historic, 2007-2014
  • Table 72: Viscosupplementation Market, Japan, Volume (Units), Historic, 2007-2014
  • Table 73: Bone Grafts and Substitutes Market, Japan, Volume (Units), Forecast, 2014-2021
  • Table 74: Bone Growth Stimulators Market, Japan, Volume (Units), Forecast, 2014-2021
  • Table 75: Viscosupplementation Market, Japan, Volume (Units), Forecast, 2014-2021
  • Table 76: Orthobiologics Market, Japan, Average Price ($) Historic, 2007-2014
  • Table 77: Orthobiologics Market, Japan, Average Price ($), Forecast, 2014-2021
  • Table 78: Orthobiologics Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 79: Orthobiologics Market, Japan, Company Share by Revenue ($m), USD Constant, 2014
  • Table 80: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 81: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 82: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 83: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 84: Orthobiologics Market, South Korea, Volume (Units), Historic, 2007-2014
  • Table 85: Orthobiologics Market, South Korea, Volume (Units), Forecast, 2014-2021
  • Table 86: Bone Grafts and Substitutes Market, South Korea, Volume (Units), Historic, 2007-2014
  • Table 87: Bone Grafts and Substitutes Market, South Korea, Volume (Units), Forecast, 2014-2021
  • Table 88: Orthobiologics Market, South Korea, Average Price ($) Historic, 2007-2014
  • Table 89: Orthobiologics Market, South Korea, Average Price ($), Forecast, 2014-2021
  • Table 90: Orthobiologics Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 91: Orthobiologics Market, South Korea, Company Share by Revenue ($m), USD Constant, 2014
  • Table 92: Orthobiologics Market Pipeline Products
  • Table 93: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Orthobiologics Market, Cross Country Comparison, Asia-Pacific, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Orthobiologics Market, Asia-Pacific, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Orthobiologics Market, Asia-Pacific, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Orthobiologics Market, Asia-Pacific, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Orthobiologics Market, Asia-Pacific, Volume (Units), 2007-2021
  • Figure 6: Orthobiologics Market, Asia-Pacific, Volume (Units), Historic, 2007-2014
  • Figure 7: Orthobiologics Market, Asia-Pacific, Volume (Units), Forecast, 2014-2021
  • Figure 8: Orthobiologics Market, Asia-Pacific, Company Share (%) 2014
  • Figure 9: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Orthobiologics Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 12: Bone Grafts and Substitutes Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 13: Orthobiologics Market, Australia, Volume (Units), Historic, 2007-2014
  • Figure 14: Orthobiologics Market, Australia, Volume (Units), Forecast, 2014-2021
  • Figure 15: Bone Grafts and Substitutes Market, Australia, Volume (Units), Historic, 2007-2014
  • Figure 16: Bone Grafts and Substitutes Market, Australia, Volume (Units), Forecast, 2014-2021
  • Figure 17: Orthobiologics Market, Australia, Company Share (%) 2014
  • Figure 18: Orthobiologics Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Orthobiologics Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 21: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 22: Viscosupplementation Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 23: Bone Grafts and Substitutes Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 24: Bone Growth Stimulators Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 25: Viscosupplementation Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 26: Orthobiologics Market, China, Volume (Units), Historic, 2007-2014
  • Figure 27: Orthobiologics Market, China, Volume (Units), Forecast, 2014-2021
  • Figure 28: Bone Grafts and Substitutes Market, China, Volume (Units), Historic, 2007-2014
  • Figure 29: Bone Growth Stimulators Market, China, Volume (Units), Historic, 2007-2014
  • Figure 30: Viscosupplementation Market, China, Volume (Units), Historic, 2007-2014
  • Figure 31: Bone Grafts and Substitutes Market, China, Volume (Units), Forecast, 2014-2021
  • Figure 32: Bone Growth Stimulators Market, China, Volume (Units), Forecast, 2014-2021
  • Figure 33: Viscosupplementation Market, China, Volume (Units), Forecast, 2014-2021
  • Figure 34: Orthobiologics Market, China, Company Share (%) 2014
  • Figure 35: Orthobiologics Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 36: Orthobiologics Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 37: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 38: Viscosupplementation Market, India, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 39: Bone Grafts and Substitutes Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 40: Bone Growth Stimulators Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 41: Viscosupplementation Market, India, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 42: Orthobiologics Market, India, Volume (Units), Historic, 2007-2014
  • Figure 43: Orthobiologics Market, India, Volume (Units), Forecast, 2014-2021
  • Figure 44: Bone Grafts and Substitutes Market, India, Volume (Units), Historic, 2007-2014
  • Figure 45: Viscosupplementation Market, India, Volume (Units), Historic, 2007-2014
  • Figure 46: Bone Grafts and Substitutes Market, India, Volume (Units), Forecast, 2014-2021
  • Figure 47: Bone Growth Stimulators Market, India, Volume (Units), Forecast, 2014-2021
  • Figure 48: Viscosupplementation Market, India, Volume (Units), Forecast, 2014-2021
  • Figure 49: Orthobiologics Market, India, Company Share (%) 2014
  • Figure 50: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 51: Orthobiologics Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 52: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 53: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 54: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 55: Bone Grafts and Substitutes Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 56: Bone Growth Stimulators Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 57: Viscosupplementation Market, Japan, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 58: Orthobiologics Market, Japan, Volume (Units), Historic, 2007-2014
  • Figure 59: Orthobiologics Market, Japan, Volume (Units), Forecast, 2014-2021
  • Figure 60: Bone Grafts and Substitutes Market, Japan, Volume (Units), Historic, 2007-2014
  • Figure 61: Bone Growth Stimulators Market, Japan, Volume (Units), Historic, 2007-2014
  • Figure 62: Viscosupplementation Market, Japan, Volume (Units), Historic, 2007-2014
  • Figure 63: Bone Grafts and Substitutes Market, Japan, Volume (Units), Forecast, 2014-2021
  • Figure 64: Bone Growth Stimulators Market, Japan, Volume (Units), Forecast, 2014-2021
  • Figure 65: Viscosupplementation Market, Japan, Volume (Units), Forecast, 2014-2021
  • Figure 66: Orthobiologics Market, Japan, Company Share (%) 2014
  • Figure 67: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 68: Orthobiologics Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 69: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 70: Bone Grafts and Substitutes Market, South Korea, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 71: Orthobiologics Market, South Korea, Volume (Units), Historic, 2007-2014
  • Figure 72: Orthobiologics Market, South Korea, Volume (Units), Forecast, 2014-2021
  • Figure 73: Bone Grafts and Substitutes Market, South Korea, Volume (Units), Historic, 2007-2014
  • Figure 74: Bone Grafts and Substitutes Market, South Korea, Volume (Units), Forecast, 2014-2021
  • Figure 75: Orthobiologics Market, South Korea, Company Share (%) 2014
  • Figure 76: GlobalData Epidemiology-Based Forecasting Model
  • Figure 77: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 78: Primary Interviews by Participant Type (%)
Back to Top